Catalyst Wire Dossier Catalyst Wire Dossier

Melflufen

melphalan flufenamide · Oncopeptides AB
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Melflufen, covering 2020-08-24 to 2025-04-01. Get the full timeline:

Most recent: Clinical Trial Update: Melflufen for Elderly Patients With Relapsed Myeloma [Phase 2]

See pricing